Niagen Bioscience (NAGE) Retained Earnings (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Retained Earnings data on file, last reported at $240.5 million in Q1 2026.

• On a quarterly basis, Retained Earnings rose 3.6% year-over-year to $240.5 million in Q1 2026; TTM through Mar 2026 was $240.5 million, a 3.6% increase from a year earlier, with the FY2025 full-year figure at $241.0 million, up 232.48% from the prior year.
• Retained Earnings for Q1 2026 stood at $240.5 million, roughly flat from $241.0 million in the prior quarter.
• Over the last five years, Retained Earnings for NAGE reached as high as $241.0 million in Q4 2025 and fell as low as -$191.0 million in Q1 2024.
• Historically, Retained Earnings has averaged $56.6 million across 5 years, with a median of $214.1 million in 2022.
• Across the five-year window, Retained Earnings tumbled 193.04% in 2023 and soared 232.48% in 2025, its largest moves.
• Year by year, Retained Earnings stood at $214.1 million in 2022, then rose by 2.22% to $218.8 million in 2023, then slumped by 183.12% to -$181.9 million in 2024, then surged by 232.48% to $241.0 million in 2025, then decreased by 0.22% to $240.5 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $240.5 million in Q1 2026, $241.0 million in Q4 2025, and $239.3 million in Q3 2025.